Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2025-12-26 @ 2:14 AM
Study NCT ID:
NCT04964505
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-08-01
First Post:
2021-07-07
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Uproleselan, Azacitidine, and Venetoclax for the Treatment of Treatment Naive Acute Myeloid Leukemia
Sponsor:
Brian Jonas
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-02
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-10
Completion Date Type:
ESTIMATED
First Submit Date:
2021-07-07
First Submit QC Date:
None
Study First Post Date:
2021-07-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-30
Last Update Post Date:
2024-08-01
Last Update Post Date Type:
ACTUAL